1. Network CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(1):330.
https://doi.org/10.1038/nature11252PMid:22810696 PMCid:PMC3401966
|
|
|
|
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(1):525-32. https://doi.org/10.1056/NEJM198809013190901PMid:2841597
|
|
|
4. Sideris M, Papagrigoriadis S. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anti-cancer Res. 2014;34(1):2061-8.
|
|
|
5. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1.0: Cancer incidence and mortality worldwide: IARC CancerBase 11. Int J Cancer. 2013.
|
|
|
|
|
|
7. Schultz DJ, Wickramasinghe NS, Ivanova MM, Isaacs SM, Dougherty SM, Imbert-Fernandez Y, Cunningham AR, Chen C, Klinge CM. Anacardic acid inhibits estrogen receptor α-DNA binding and reduces target gene transcription and breast cancer cell proliferation. Mol Cancer Ther. 2010;9(1):594-605. https://doi.org/10.1158/1535-7163.MCT-09-0978PMid:20197399 PMCid:PMC2837512
|
|
|
8. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171-80. https://doi.org/10.1002/ijc.24343PMid:19350627
|
|
|
|
|
|
10. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III, Fuchs CS. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(1):433-40. https://doi.org/10.1200/JCO.2003.07.125PMid:12560431
|
|
|
|
|
|
12. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(1):683-91. https://doi.org/10.1136/gutjnl-2015-310912PMid:26818619
|
|
|
13. Qudayr A, Kabel AM, AbdElmaaboud MA, Alghamdi WY, Alghorabi A. Colorectal cancer: new perspectives. J Cancer Res Treat. 2018;6(1):80-3.
|
|
|
14. Erhatić R, Vukobratović M, Peremin Volf T, Židovec V. Morphological and chemical properties of selected sweet violet populations. J Cent Eur Agric. 2010;11(1):55-64. https://doi.org/10.5513/JCEA01/11.1.803
|
|
|
15. Koochek M, Pipelzadeh M, Mardani H. The effectiveness of Viola odorata in the prevention and treatment of formalin-induced lung damage in the rat. J Herbs Spices Med Plants. 2003;10(1):95-103. https://doi.org/10.1300/J044v10n02_11
|
|
|
|
|
|
17. Siddiqi HS, Mehmood MH, Rehman NU, Gilani AH. Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extract. Lipids Health Dis. 2012;11(1):1-12. https://doi.org/10.1186/1476-511X-11-6PMid:22233644 PMCid:PMC3286389
|
|
|
18. Gerlach SL, Rathinakumar R, Chakravarty G, Göransson U, Wimley WC, Darwin SP, Mondal D. Anti-cancer and chemosensitizing abilities of cycloviolacin O2 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Pept Sci. 2010;94(1):617-25. https://doi.org/10.1002/bip.21435PMid:20564026
|
|
|
19. Lindholm P, Göransson U, Johansson S, Claeson P, Gullbo J, Larsson R, Bohlin L, Backlund A. Cyclotides: A novel type of cytotoxic agents. Mol Cancer Ther. 2002;1(1):365-9.
|
|
|
20. Yousefnia S, Naseri D, Seyed Forootan F, Tabatabaeian M, Moattar F, Ghafghazi T, Nasr Esfahani M, Ghaedi K. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells. Clin Transl Oncol. 2020;22(1):1619-34. https://doi.org/10.1007/s12094-020-02307-9PMid:32056127
|
|
|
21. Alipanah H, Bigdeli MR, Esmaeili MA. Inhibitory effect of Viola odorata extract on tumor growth and metastasis in 4T1 breast cancer model. Iran J Pharm Res. 2018; 17:276.
|
|
|
22. Deldadeh N. Evaluation and comparison of antimicrobial and anti-cancer effects of aqueous and ethanolic extracts of violet. Multidiscip Cancer Investig. 2022; 6:0-0.
|
|
|
23. Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Bahramian F, Bekhradnia AR. Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata, B. hyrcana and C. speciosum. Pak J Pharm Sci. 2010; 23:29-34.
|
|
|
24. Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry. 1995;34(14):4147-58. https://doi.org/10.1021/bi00013a002PMid:7703226
|
|
|
|
|
|
26. Li D, Wang P, Luo Y, Zhao M, Chen F. Health benefits of anthocyanins and molecular mechanisms: update from recent decade. Crit Rev Food Sci Nutr. 2017;57(8):1729-41. https://doi.org/10.1080/10408398.2015.1030064PMid:26192537
|
|
|
27. Svangård E, Burman R, Gunasekera S, Lövborg H, Gullbo J, Göransson U. Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J Nat Prod. 2007;70(4):643-7. https://doi.org/10.1021/np070007vPMid:17378610
|
|
|
28. Asadi-Samani M, Kooti W, Aslani E, Shirzad H. A systematic review of Iran's medicinal plants with anti-cancer effects. J Evid Based Complementary Altern Med. 2016;21(2):143-53. https://doi.org/10.1177/2156587215600873PMid:26297173
|
|
|
|
|
|
|
|
|
31. Rechinger KH. Flora Iranica. 1963.
|
|
|
32. Gharibi S, Tabatabaei BES, Saeidi G, Goli SAH, Talebi M. Total phenolic content and antioxidant activity of three Iranian endemic Achillea species. Ind Crops Prod. 2013; 50:154-8. https://doi.org/10.1016/j.indcrop.2013.07.038
|
|
|
33. Brangule A, Šukele R, Bandere D. Herbal medicine characterization perspectives using advanced FTIR sample techniques-diffuse reflectance (DRIFT) and photoacoustic spectroscopy (PAS). Front Plant Sci. 2020; 11:356. https://doi.org/10.3389/fpls.2020.00356PMid:32362902 PMCid:PMC7182013
|
|
|
34. Gharibi S, Tabatabaei BES, Saeidi G, Talebi M, Matkowski A. The effect of drought stress on polyphenolic compounds and expression of flavonoid biosynthesis related genes in Achillea pachycephala Rech. f. Phytochemistry. 2019; 162:90-8. https://doi.org/10.1016/j.phytochem.2019.03.004PMid:30875522
|
|
|
35. Zhang LC, Jin X, Huang Z, Yan ZN, Li PB, Duan RF, Feng H, Jiang JH, Peng H, Liu W Protective effects of choline against hypoxia-induced injuries of vessels and endothelial cells. Exp Ther Med. 2017; 13:2316-24. https://doi.org/10.3892/etm.2017.4276PMid:28565844 PMCid:PMC5443310
|
|
|
36. Horibata S, Vo TV, Subramanian V, Thompson PR, Coonrod SA. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J Vis Exp. 2015; e52727. https://doi.org/10.3791/52727-vPMid:26067809 PMCid:PMC4542786
|
|
|
37. Yang T, Zhai H, Yan R, Zhou Z, Gao L, Wang L. lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line. Braz J Med Biol Res. 2018;51. https://doi.org/10.1590/1414-431x20187046PMid:29791590 PMCid:PMC6002139
|
|
|
38. Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. 2019; 68:1820-6. https://doi.org/10.1136/gutjnl-2018-317592PMid:31097539 PMCid:PMC6839794
|
|
|
39. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008; 134:1570-95. https://doi.org/10.1053/j.gastro.2008.02.002PMid:18384785
|
|
|
40. Chabner B, Longo D. Clinical strategies for cancer treatment: the role of drugs. In: Cancer Chemotherapy and Biotherapy: Principles and Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
|
|
|
41. Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients' opinion about starvation-based differential chemotherapy. J Cancer Ther. 2014;2014. https://doi.org/10.4236/jct.2014.58089
|
|
|
42. Safarzadeh E, Shotorbani SS, Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull. 2014; 4:421.
|
|
|
|
|
|
44. Skowyra M, Calvo MI, Gallego Iradi MG, Azman NABM, Almajano Pablos MP. Characterization of phytochemicals in petals of different colours from Viola×wittrockiana Gams and their correlation with antioxidant activity. J Agric Sci. 2014; 6:93-105. https://doi.org/10.5539/jas.v6n9p93
|
|
|
45. Selvakumar P, Badgeley A, Murphy P, Anwar H, Sharma U, Lawrence K, Lakshmikuttyamma A. Flavonoids and other polyphenols act as epigenetic modifiers in breast cancer. Nutrients. 2020; 12:761. https://doi.org/10.3390/nu12030761PMid:32183060 PMCid:PMC7146477
|
|
|
46. Mahboubi M, Kashani LMT. A narrative study about the role of Viola odorata as traditional medicinal plant in management of respiratory problems. Adv Integr Med. 2018; 5:112-8. https://doi.org/10.1016/j.aimed.2017.12.003
|
|
|
47. Sarker U, Oba S. Polyphenol and flavonoid profiles and radical scavenging activity in leafy vegetable Amaranthus gangeticus. BMC Plant Biol. 2020; 20:1-12. https://doi.org/10.1186/s12870-020-02700-0PMid:33138787 PMCid:PMC7607633
|
|
|
48. Sato Y, Itagaki S, Kurokawa T, Ogura J, Kobayashi M, Hirano T, Sugawara M, Iseki K. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm. 2011; 403:136-8. https://doi.org/10.1016/j.ijpharm.2010.09.035PMid:20933071
|
|
|
|
|
|
50. Herrmann A, Svangård E, Claeson P, Gullbo J, Bohlin L, Göransson U. Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell Mol Life Sci. 2006; 63:235-45. https://doi.org/10.1007/s00018-005-5486-4PMid:16389447 PMCid:PMC11136400
|
|
|
|
|
|
52. El-Kott AF, Abd-El-Karim M, Khalifa HS, Morsy K, Ibrahim EH, Bin-Jumah M, Abdel-Daim MM, Aleya L. Kaempferol protects against cadmium chloride-induced hippocampal damage and memory deficits by activation of silent information regulator 1 and inhibition of poly (ADP-Ribose) polymerase-1. Sci Total Environ. 2020; 728:138832. https://doi.org/10.1016/j.scitotenv.2020.138832PMid:32353801
|
|
|
|
|
|
54. Zeinoddini S, Nabiuni M, Jalali H. The synergistic cytotoxic effects of doxorubicin and Viola odorata extract on human breast cancer cell line T47-D. J Cancer Res Ther. 2019; 15:1073. https://doi.org/10.4103/jcrt.JCRT_990_17PMid:31603113
|
|
|
55. Rauf A, Imran M, Khan IA, ur-Rehman M, Gilani SA, Mehmood Z, Mubarak MS. Anti-cancer potential of quercetin: A comprehensive review. Phytother Res. 2018; 32:2109-30. https://doi.org/10.1002/ptr.6155PMid:30039547
|
|
|
56. McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res. 2011; 13:1-14. https://doi.org/10.1186/bcr2853PMid:21429211 PMCid:PMC3219194
|
|
|
57. Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochem Biophys Res Commun. 2015; 465:702-13. https://doi.org/10.1016/j.bbrc.2015.08.053PMid:26299922
|
|
|
58. Tuasha N, Seifu D, Gadisa E, Petros B, Oredsson S. Solvent fractions of selected Ethiopian medicinal plants used in traditional breast cancer treatment inhibit cancer stem cells in a breast cancer cell line. BMC Complement Med Ther. 2020; 20:1-9 https://doi.org/10.1186/s12906-020-03154-5PMid:33238963 PMCid:PMC7687706
|
|
|